DIABETIC GASTROPARESIS TREATMENT MARKET ANALYSIS

Diabetic Gastroparesis Treatment MarketSize and Trends

The Global Diabetic Gastroparesis Treatment Market is estimated to be valued at US$  2,271.7 million in 2023 and is expected to exhibit a CAGR of 3.6 % during the forecast period (2023-2030).

Figure 1. Global Diabetic Gastroparesis Treatment Market Share (%), by Product Type, 2023

Global Diabetic Gastroparesis Treatment Market – Driver

Increasing Prevalence of Diabetes Worldwide

The growing diabetes mellitus population worldwide is a major factor leading to the high demand for diabetic gastroparesis drugs. For instance, according to the data published by International Diabetes Federation in September 2021, it is estimated that approximately 537 million adults will be living with diabetes in 2021, and the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. It is also estimated that 3 in 4 adults with diabetes will live in low- and middle-income countries in 2021. Furthermore, according to an article published by Frontiers journal in March 2022, a study in India showed that the prevalence of diabetes mellitus in India was 9.3%. Among those with diabetes mellitus, 45.8% were aware, 36.1% were on treatment, and 15.7% had it under control. Hence, with the increasing prevalence of diabetes, diabetic gastroparesis is also expected to increase, thus enhancing growth of global diabetic gastroparesis market .

Figure 2. Global Diabetic Gastroparesis Treatment Market Value (US$ Million), by Region, 2023